(Q33735400)

29 July 2017

1 reference

title

Pharmacologic considerations for therapeutic success with antiretroviral agents (English)

1 reference

29 July 2017

main subject

anti-retroviral agent

0 references

author name string

C V Fletcher

series ordinal

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

Annals of Pharmacotherapy

29 July 2017

published in

1 reference

29 July 2017

volume

33

1 reference

29 July 2017

issue

9

1 reference

29 July 2017

page(s)

989-995

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

29 July 2017

cites work

1 reference

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

21 January 2018

1 reference

Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development

21 January 2018

1 reference

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

21 January 2018

1 reference

The human drug metabolizing cytochromes P450.

21 January 2018

1 reference

Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors

21 January 2018

1 reference

Enzymatic assay for measurement of zidovudine triphosphate in peripheral blood mononuclear cells

21 January 2018

1 reference

Cellular pharmacology of 2',3'-dideoxy-2',3'-didehydrothymidine, a nucleoside analog active against human immunodeficiency virus

21 January 2018

1 reference

Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models

21 January 2018

1 reference

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

21 January 2018

1 reference

Clinical pharmacokinetics of zidovudine: inter and intraindividual variability and relationship to long term efficacy and toxicity.

21 January 2018

1 reference

Dideoxyinosine in Children with Symptomatic Human Immunodeficiency Virus Infection

21 January 2018

1 reference

Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected children.

21 January 2018

1 reference

High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection

21 January 2018

1 reference

Pharmacokinetics, safety, and activity of nevirapine in human immunodeficiency virus type 1-infected children

21 January 2018

1 reference

The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.

21 January 2018

1 reference

A pilot study of nevirapine, indinavir, and lamivudine among patients with advanced human immunodeficiency virus disease who have had failure of combination nucleoside therapy

21 January 2018

1 reference

The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy.

21 January 2018

1 reference

Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir

21 January 2018

1 reference

Ritonavir and saquinavir combination therapy for the treatment of HIV infection

21 January 2018

1 reference

Therapeutic drug monitoring

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.19075

1 reference

29 July 2017

1 reference